fda status bpc-157 2024 RFK Jr pushes for approval of peptide | Eric Topol, MD posted on the topic BPC-157 FDA Approval Status: Is
Description
My guess still remains that there's been an error in the process somewhere and it's 'crept out'
Rather than targeting growth hormone pathways directly, this combination is typically examined in models related to tissue repair and structural support
They are commonly used by patients who: They work best when combined with: Lipotropic compounds assist the liver in breaking down fat and optimizing metabolic processes
The alcohol irritates subcutaneous tissue and causes a burning sensation that gets misidentified as a medication reaction
